HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of endogenous receptors for carbohydrate ligands in primary and metastatic human renal cell carcinoma.

Abstract
Frozen sections of primary and metastatic human renal cell carcinoma (RCC) were analyzed for the expression of endogenous binding sites for carbohydrates. Fluorescent neoglycoproteins, carrying chemically linked carbohydrate residues on bovine serum albumin as a carrier protein, were applied to 44 primary tumor specimens. In the majority of specimens, accessible binding sites with specificity for maltose and N-acetylgalactosamine were detected. In specimens of normal kidney no specific binding of carbohydrate ligands was observed under these experimental conditions. Specimens of both the primary tumor and a metastasis were available in 10 cases. When the expression of specific binding sites of primary tumors and metastases was compared, the respective patterns were similar with no clear gain or loss of certain lectins in the metastases. We conclude that binding sites with specificity for maltose and N-acetylgalactosamine are present on human RCC and their corresponding metastases.
AuthorsH Buszello, H J Gabius, R Ackermann, R Heicappell
JournalUrological research (Urol Res) Vol. 21 Issue 4 Pg. 293-9 ( 1993) ISSN: 0300-5623 [Print] Germany
PMID8212420 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ligands
  • Receptors, Cell Surface
  • Maltose
  • Acetylgalactosamine
Topics
  • Acetylgalactosamine (metabolism)
  • Carbohydrate Metabolism
  • Carcinoma, Renal Cell (metabolism, secondary)
  • Female
  • Humans
  • Kidney Neoplasms (metabolism)
  • Ligands
  • Male
  • Maltose (metabolism)
  • Middle Aged
  • Receptors, Cell Surface (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: